Changes in Stage 3A NSCLC Using Immunotherapy In Resectable Patients - 102262

Spotlight
Video

Changes in Stage 3A NSCLC Using Immunotherapy In Resectable Patients

Loading........
Description: Jessica S. Donington, MD of NYU Langone Health discusses the changes in stage 3A NSCLC using immunotherapy in resectable patients from the 22nd Annual Perspectives in Thoracic Oncology in New York http://imedex.com/perspecti...
Shared By : thoraciconcology
Posted on : 12/28/17
Added : 24 days ago



Recommended

Nothing found.

More From thoraciconcology

Nothing found.